For Research Purposes Only — Not intended for human consumption or therapeutic use

Retatrutide for Women
Best Seller — Weight Wellness

The Only Peptide
That Hits Three
Receptors at Once

Retatrutide simultaneously activates GIP, GLP-1, and glucagon receptors — the most advanced tri-agonist peptide available. Designed for women whose bodies have stopped responding to conventional approaches.

Receptor Targets

GIP · GLP-1 · Glucagon

99.1%

HPLC Purity

3rd Party Verified

$129

Per 10mg Vial

Free shipping over $200

Learn How It Works

Formulated for women's hormonal biology · ISO/IEC 17025 certified · Discreet insulated shipping

The Science

How Retatrutide Works

Most weight loss peptides target a single receptor. Retatrutide is the only tri-agonist that fires all three metabolic pathways at once — delivering results that single-action compounds simply cannot match.

GIP Receptor

Insulin Sensitivity & Fat Burning

GIP (Glucose-dependent Insulinotropic Polypeptide) activation dramatically improves insulin sensitivity — the root cause of weight gain in most women over 35. It also directly triggers fat cell lipolysis, releasing stored fat for energy.

  • ↑ Insulin sensitivity
  • ↑ Fat cell mobilization
  • ↓ Visceral fat storage

GLP-1 Receptor

Appetite & Satiety Control

GLP-1 (Glucagon-Like Peptide-1) activation sends powerful fullness signals to the brain's hunger centers, slows gastric emptying for prolonged satisfaction, and eliminates the hormonal cravings that derail diets.

  • ↓ Appetite & cravings
  • ↑ Satiety duration
  • ↓ Emotional eating triggers

Glucagon Receptor

Fat Oxidation & Energy Burn

Glucagon receptor agonism is the third lever unique to Retatrutide. It directly activates fat oxidation — the process of burning stored fat for energy — and increases resting metabolic rate even between meals.

  • ↑ Fat oxidation rate
  • ↑ Resting metabolism
  • ↑ Energy expenditure
Retatrutide for Women
Designed for Female Biology

Why This Works When Nothing Else Did

After 35, declining estrogen, shifting progesterone, and increasing cortisol fundamentally change how your body stores and burns fat. The result: the calorie-cutting and exercise routines that worked in your 20s stop working. This isn't willpower failure — it's biology.

Retatrutide's tri-receptor mechanism directly addresses all three hormonal weight drivers simultaneously. GIP activation compensates for estrogen's declining effect on insulin sensitivity. GLP-1 activation restores the hunger signaling that hormonal fluctuations disrupt. Glucagon activation rebuilds the metabolic rate that slows with age.

The result is weight loss that feels different — sustainable, hormonal, and aligned with your body rather than fighting against it.

Addresses hormonal weight resistance

Preserves lean muscle mass

Sustainable fat-focused loss

Restores metabolic rate

Step-by-Step Protocol

Dosing Guide

Retatrutide is most effective with a gradual titration approach. Always start low and work with a qualified healthcare provider for personalized dosing.

Weeks 1–4

Adaptation Phase

0.5 mg/ Once weekly

Starting low allows your body to adapt to the compound and minimizes early GI adjustment symptoms. Most women begin noticing reduced appetite within the first 7–10 days.

  • Inject same day each week
  • Stay well hydrated
  • Log any notable changes

Weeks 5–8

Building Phase

1 mg/ Once weekly

This is where most women begin seeing consistent, measurable fat loss. Appetite suppression is well-established and metabolic changes become visible in body composition.

  • Take progress photos weekly
  • Track energy levels
  • Combine with moderate movement

Weeks 9–12

Active Results Phase

2 mg/ Once weekly

Full tri-receptor activation is achieved. Fat oxidation and metabolic rate increases become most pronounced. This phase typically produces the most dramatic visible body composition changes.

  • Schedule DEXA scan or measurements
  • Consider stacking with MOTS-C
  • Maintain protein intake ≥ 1g/lb goal weight

Week 13+

Optimization Phase

2–4 mg/ Provider-guided

Work with your healthcare provider to optimize dose based on results and tolerance. Some women maintain at 2mg; others titrate higher for continued progress or transition to maintenance protocols.

  • Review bloodwork with provider
  • Consider cycling protocols
  • Assess long-term maintenance goals

Reconstitution Instructions

01

Gather Supplies

Retatrutide vial, bacteriostatic water (BW), 1ml insulin syringe, alcohol wipes, sharps container.

02

Clean & Wipe

Wipe the top of both the peptide vial and BW vial with an alcohol swab. Allow to dry for 30 seconds.

03

Draw the Water

Draw the recommended volume of BW (typically 1–2ml) into your syringe slowly.

04

Add to Vial

Insert needle into the peptide vial and inject BW slowly along the glass wall — never directly onto the powder.

05

Swirl Gently

Swirl the vial gently in a circular motion until fully dissolved. Never shake. Store reconstituted peptide at 2–8°C.

Dosing information is for educational purposes only. Always consult a licensed healthcare provider before starting any peptide protocol. Individual dosing may vary based on health status, weight, and provider guidance.

Side-by-Side Comparison

Retatrutide vs. The Alternatives

You've heard of Ozempic. You may have heard of Mounjaro. Here's exactly how Retatrutide stacks up — and why it consistently outperforms for women.

Feature

Best Choice

Retatrutide

Triple Agonist

Compare

Semaglutide

(Ozempic/Wegovy)

Compare

Tirzepatide

(Mounjaro/Zepbound)

Receptor Targets
GIP + GLP-1 + Glucagon
GLP-1 only
GIP + GLP-1
Mechanism Type
Triple Agonist
Single Agonist
Dual Agonist
Appetite Suppression
Very Strong
Strong
Strong
Direct Fat Oxidation
Resting Metabolic Rate ↑
Insulin Sensitivity ↑
Avg. Clinical Weight Loss
~24–30%
~15–17%
~20–22%
Muscle Preservation
Superior
Moderate
Good
Lean-to-Fat Loss Ratio
Best in Class
Moderate
Good
Weekly Injection
Suited for Hormonal Weight Gain
Optimal
Partial
Good
Available at Rejuven
Price per 10mg vial
$129.99
$129.99
$129.99

The Bottom Line

Semaglutide (Ozempic) opened the door. Tirzepatide improved on it. Retatrutide is the evolution — the only compound that directly activates fat oxidation through glucagon receptors in addition to GLP-1 and GIP pathways. For women who haven't seen the results they expected from other peptides, or who are dealing with the hormonal weight resistance of perimenopause, Retatrutide represents the most advanced available option.

Everything You Need to Know

Frequently Asked Questions

Ozempic (semaglutide) is a GLP-1 receptor agonist — it activates one metabolic receptor. Retatrutide is a triple agonist that activates three receptors simultaneously: GLP-1 (appetite and satiety), GIP (insulin sensitivity and fat storage), and glucagon (direct fat oxidation and metabolic rate). The glucagon receptor component is what truly distinguishes Retatrutide — no other approved or widely available weight management compound directly activates fat burning at the cellular level the way glucagon agonism does.

Still have questions?

Our women's wellness team is available to help you find the right protocol.

Email Our Team
Buy Retatrutide
Ready to Transform?

Start Your Retatrutide
Protocol Today

99.1% HPLC purity. Third-party verified. Formulated for women's hormonal biology. Discreet insulated shipping. Your transformation starts with a single step.

99.1% Purity — Lab Verified
Cold-Pack Insulated Shipping
Women-Formulated Protocol

Your Cart

Your cart is empty

Explore our clinical-grade peptides and add your protocol.